Literature DB >> 21336897

Isolation and Culture of Human Alveolar Type II Pneumocytes.

I R Witherden1, T D Tetley.   

Abstract

Alveolar type II pneumocytes (alveolar type II cells; TII cells) play an important role in the homeostasis of the alveolar unit. They are the progenitor cells to the type I pneumocyte and are therefore responsible for regeneration of alveolar epithelium following alveolar epithelial cell damage. The type I cell covers over 90% of the alveolar surface, reflecting its capacity to stretch into a flattened cell with very little depth (approx. 0.1 µm), but with a large surface area, to facilitate gas exchange. Nevertheless, the type II cell outnumbers type I cells, estimated to be by 2:1 in rodents. Most of the type II cell lies buried in the interstitium of the alveolus, with only the apical tip of the cell reaching into the airspace, through which another crucial function, provision of alveolar surfactant, occurs. Surfactant synthesis and secretion is a unique feature of type II cells; surfactant consists of a high proportion of phospholipids (approx. 90%) and a small proportion of protein (approx. 10%), which contains surfactant apoprotein (SP), of which four have so far been described, SP-A, SP-B, SP-C, and SP-D (1,2). Surfactant is highly surface active and is essential to prevent alveolar collapse. In addition, surfactant has many other roles, including pulmonary host defense. Compromised surfactant synthesis and function are believed to be a feature of numerous disease states (1,2), including infant respiratory distress syndrome, adult respiratory distress syndrome, alveolar proteinosis, and microbial infection.

Entities:  

Year:  2001        PMID: 21336897     DOI: 10.1385/1-59259-151-5:137

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  15 in total

1.  Multi-walled carbon nanotube length as a critical determinant of bioreactivity with primary human pulmonary alveolar cells.

Authors:  Sinbad Sweeney; Deborah Berhanu; Superb K Misra; Andrew J Thorley; Eugenia Valsami-Jones; Teresa D Tetley
Journal:  Carbon N Y       Date:  2014-11-01       Impact factor: 9.594

2.  Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.

Authors:  Marybeth Langer; Elizabeth Stewart Duggan; John Leland Booth; Vineet Indrajit Patel; Ryan A Zander; Robert Silasi-Mansat; Vijay Ramani; Tibor Zoltan Veres; Frauke Prenzler; Katherina Sewald; Daniel M Williams; Kenneth Mark Coggeshall; Shanjana Awasthi; Florea Lupu; Dennis Burian; Jimmy Dale Ballard; Armin Braun; Jordan Patrick Metcalf
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

3.  Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.

Authors:  Olivier E Pardo; Adeline Lesay; Alexandre Arcaro; Rita Lopes; Bee Ling Ng; Patricia H Warne; Iain A McNeish; Teresa D Tetley; Nicholas R Lemoine; Huseyin Mehmet; Michael J Seckl; Julian Downward
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

4.  Validation of an in vitro exposure system for toxicity assessment of air-delivered nanomaterials.

Authors:  Jong Sung Kim; Thomas M Peters; Patrick T O'Shaughnessy; Andrea Adamcakova-Dodd; Peter S Thorne
Journal:  Toxicol In Vitro       Date:  2012-09-05       Impact factor: 3.500

5.  Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and type-II epithelial cells.

Authors:  Sinbad Sweeney; Ioannis G Theodorou; Marta Zambianchi; Shu Chen; Andrew Gow; Stephan Schwander; Junfeng Jim Zhang; Kian Fan Chung; Milo S P Shaffer; Mary P Ryan; Alexandra E Porter; Teresa D Tetley
Journal:  Nanoscale       Date:  2015-06-21       Impact factor: 7.790

6.  Differential bioreactivity of neutral, cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cells.

Authors:  Pakatip Ruenraroengsak; Teresa D Tetley
Journal:  Part Fibre Toxicol       Date:  2015-07-02       Impact factor: 9.400

7.  Functional consequences for primary human alveolar macrophages following treatment with long, but not short, multiwalled carbon nanotubes.

Authors:  Sinbad Sweeney; Davide Grandolfo; Pakatip Ruenraroengsak; Teresa D Tetley
Journal:  Int J Nanomedicine       Date:  2015-04-23

8.  Differential response to bacteria, and TOLLIP expression, in the human respiratory tract.

Authors:  Olga Lucia Moncayo-Nieto; Thomas S Wilkinson; Mairi Brittan; Brian J McHugh; Richard O Jones; Andrew Conway Morris; William S Walker; Donald J Davidson; A John Simpson
Journal:  BMJ Open Respir Res       Date:  2014-09-11

9.  Contribution of CFTR to alveolar fluid clearance by lipoxin A4 via PI3K/Akt pathway in LPS-induced acute lung injury.

Authors:  Yi Yang; Yang Cheng; Qing-Quan Lian; Li Yang; Wei Qi; De-Rong Wu; Xia Zheng; Yong-Jian Liu; Wen-Juan Li; Sheng-Wei Jin; Fang Gao Smith
Journal:  Mediators Inflamm       Date:  2013-05-16       Impact factor: 4.711

10.  Translocation of Functionalized Multi-Walled Carbon Nanotubes across Human Pulmonary Alveolar Epithelium: Dominant Role of Epithelial Type 1 Cells.

Authors:  Pakatip Ruenraroengsak; Shu Chen; Sheng Hu; Jodie Melbourne; Sinbad Sweeney; Andrew J Thorley; Jeremy N Skepper; Milo S P Shaffer; Teresa D Tetley; Alexandra E Porter
Journal:  ACS Nano       Date:  2016-04-21       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.